MEDIUM confidence: 100% data completeness, but the composite (59) sits in the indecisive 30–70 range — strong-buy and short calls require a more decisive composite. What does confidence mean?
Technical context for active traders — derived from price, the 50/200-day moving averages, the 52-week range, and recent volume. Not part of the QScore.
Fama-French 5-factor (2×3) + Momentum, monthly OLS with Newey-West errors. Bars show signed factor betas; faded bars/figures aren't statistically significant.
Dated events from the market calendar; the “also watch” items are AI-generated observations from QScoring data. Informational only — not investment advice, and dates can change.
AI classification of policy/regulatory sensitivity from the company's sector, industry, and business description. Exposure/sensitivity only — not a political opinion, a prediction of government action, or investment advice. As of 2026-07-10.
| Metric (USD) | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
| Revenue | $2.1B— | $2.6B+20.5% | $3.2B+25.2% | $3.7B+13.4% | $4.5B+22.7% |
| EPS (dil.) | $-0.82— | $2.15n/m | $0.77-64.2% | $-0.12-115.6% | $2.15n/m |
| Free Cash Flow | $464M— | $243M-47.6% | $193M-20.6% | $492M+154.9% | $751M+52.6% |
| Gross Margin | 30.3% | 32.0%+1.7pp | 30.5%-1.5pp | 31.9%+1.4pp | 24.9%-6.9pp |
| Operating Margin | 1.9% | 6.7%+4.9pp | 9.2%+2.5pp | 7.9%-1.4pp | 13.5%+5.6pp |
| Net Margin | -8.9% | 21.7%+30.6pp | 5.7%-15.9pp | -0.8%-6.6pp | 12.4%+13.2pp |
Absolute figures with year-over-year change. Margins show the level with the change in percentage points (pp). “n/m” = not meaningful (prior ≤ 0); ⚠ marks a large percentage off a small base — read the dollar figure.
Buy-rated share 100% → 100% over ~3 months (+0pp).
| Quarter | Est. | Actual | Surprise |
|---|---|---|---|
| Aug 2026 | $0.24 | $0.02 | -91.7% |
| May 2026 | $-0.05 | $0.22 | +517.3% |
| Feb 2026 | $0.37 | $0.39 | +6.2% |
| Nov 2025 | $0.25 | $0.24 | -4.6% |
| Aug 2025 | $0.63 | $1.52 | +143.2% |
| May 2025 | $-0.10 | $0.05 | +149.8% |
| Feb 2025 | $0.43 | $-1.03 | -339.5% |
| Nov 2024 | $0.20 | $0.48 | +139.0% |
Net buyback (repurchases less issuance) ÷ market cap, plus trailing dividend yield.
No recent open-market insider transactions.
Short interest, days-to-cover, and institutional-ownership change require a data-plan upgrade (not yet available).
Forward-return IC, quintile spread & hit rate publish on /performance as the tracking panel accrues enough no-look-ahead history.
Working the DCF backward: holding the assumptions below, this is the free-cash-flow growth today's price implies over the next 10 years. It is a read on the price's embedded expectations — not a fair-value or target price.
The price implies FCF growth above the analyst consensus of 8.7%/yr (revenue basis).
Base free cash flow $479M (avg FY2023–FY2025; latest year $751M) · equity value $23.8B · levered FCF discounted at the cost of equity. Reverse DCF is illustrative, not advice.
The QScore of 59 for FWONA suggests a moderately attractive investment, driven by strong growth and momentum scores, with growth scoring particularly high at 74 due to significant revenue and EPS growth. However, the stock trades at a premium, as reflected in its value score of 45, with a P/E of 51.7. The short-term score of 63 is notably higher than the long-term score of 56, indicating recent strength. FWONA's profitability scores are relatively low, with an ROE of 5.9%, but its risk profile is more favorable, with a beta of 0.7.